Comparative Evaluate the Efficacy to Acute and Chronic Bronchitis

Summary

The Purpose of A Multicenter, Randomized, Double-blind, Placebo-controlled to Evaluate the Efficacy, Safety and Pharmacokinetics of N02RS1 600mg and 1,200mg per day in Patients With acute and acute exacerbation of chronic bronchitis for 7 days.

Timeline

Start

2013-11

Primary completion

2013-11

Completion

2014-03

Drugs

Indications